Emyria Limited Investor Briefing – 17 February
Emyria Limited (ASX: EMD) Webcast Replay
Emyria Limited (ASX: EMD) is a data-backed, drug development company. Emyria’s Treatments target unmet needs and are focused on obtaining approval from major global regulators.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Dr Michael Winlo provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 17 February 2021 at 12pm (AEDT).
Speak to the Reach Markets team